drugset / Trial / NCT01992341
AMG 386 Drug-Drug Interaction Study With Paclitaxel
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics of paclitaxel when given alone and in combination with AMG 386 to determine whether AMG 386 alters the pharmacokinetics of paclitaxel
Timeline
- Start
- 2012-07
- Primary completion
- 2013-08
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | — |
| Subject | Trebananib | Peptide | 15 mg/kg | — |